Illumina, Inc.ILMN
NasdaqGS•Healthcare•Diagnostics & Research
Analyze revenue and earnings growth — the core drivers of long-term shareholder returns.
TTM revenue reached $4.39B, growing 1.3% year-over-year. TTM net income stood at $853.00M (188.3% growth). Quarterly EBITDA was $278.00M and operating income was $209.00M. Consistent revenue and earnings growth are the primary drivers of long-term shareholder returns. Analyze ILMN growth trends across revenue, EBITDA, operating income, and net income.
Revenue and earnings growth across quarters